The interaction of antimicrobial peptide LL-37 with artificial biomembranes: epifluorescence and impedance spectroscopy approach

被引:24
作者
Neville, F
Cahuzac, M
Nelson, A
Gidalevitz, D [1 ]
机构
[1] Univ Leeds, Inst Mat Res, Leeds LS2 9JT, W Yorkshire, England
[2] Univ Leeds, Dept Chem Engn, Leeds LS2 9JT, W Yorkshire, England
[3] Univ Leeds, Ctr Self Organising Mol Syst, Leeds LS2 9JT, W Yorkshire, England
[4] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England
[5] IIT, Dept Chem & Environm Engn, Chicago, IL 60616 USA
关键词
D O I
10.1088/0953-8984/16/26/014
中图分类号
O469 [凝聚态物理学];
学科分类号
070205 ;
摘要
Membrane interactions of the human antimicrobial peptide LL-37 have been studied by a variety of techniques including insertion assay, epifluorescence microscopy and impedance spectroscopy. This study makes use of lipid monolayers at the air-aqueous interface to mimic bacterial or eukaryotic membranes. It was found that LL-37 readily inserts into phosphatidylglycerol (PG) and lipid A monolayers, significantly disrupting their structure. In contrast, the structure of phosphatidylcholine (PC) monolayers remains virtually unaffected by LL-37, which is evident both from epifluorescence and electrochemical measurements. Impedance spectroscopy showed that the LL-37 rich PC monolayer remains an ideal capacitor while LL-37 enriched lipid A capacitance decreases significantly, suggesting an increase in layer thickness from peptide-lipid binding.
引用
收藏
页码:S2413 / S2420
页数:8
相关论文
共 28 条
[1]  
Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO
[2]  
2-D
[3]   Cathelicidins - a family of multifunctional antimicrobial peptides [J].
Bals, R ;
Wilson, JM .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (04) :711-720
[4]  
Bayés M, 2003, METHOD FIND EXP CLIN, V25, P225
[5]  
Bayes M, 2002, METHOD FIND EXP CLIN, V24, P217
[6]   Bed occupancy and overcrowding as determinant factors in the incidence of MRSA infections within general ward settings [J].
Borg, MA .
JOURNAL OF HOSPITAL INFECTION, 2003, 54 (04) :316-318
[7]   Iseganan hydrochloride - Treatment of mucositis - Treatment of cystic fibrosis - Antibiotic [J].
Cullell-Young, M ;
Leeson, PA ;
del Fresno, M ;
Silvestre, J .
DRUGS OF THE FUTURE, 2002, 27 (03) :234-239
[8]   RELATION BETWEEN VARIOUS PHOSPHOLIPASE ACTIONS ON HUMAN RED-CELL MEMBRANES AND INTERFACIAL PHOSPHOLIPID PRESSURE IN MONOLAYERS [J].
DEMEL, RA ;
GEURTSVANKESSEL, WSM ;
ZWAAL, RFA ;
ROELOFSEN, B ;
VANDEENEN, LLM .
BIOCHIMICA ET BIOPHYSICA ACTA, 1975, 406 (01) :97-107
[9]   The evolution of a resistant pathogen - the case of MRSA [J].
Enright, MC .
CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (05) :474-479
[10]   Interaction of antimicrobial peptide protegrin with biomembranes [J].
Gidalevitz, D ;
Ishitsuka, YJ ;
Muresan, AS ;
Konovalov, O ;
Waring, AJ ;
Lehrer, RI ;
Lee, KYC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (11) :6302-6307